Skip to main content
. 2018 Aug 31;9:1002. doi: 10.3389/fphar.2018.01002

FIGURE 2.

FIGURE 2

In vitro binding and agonist profile of POMO at the opioid receptors. (A) Concentration-dependent inhibition by POMO and 14-OMO of [3H]DAMGO (MOR) and [3H][Ile5,6]deltorphin II (DOR) binding using rat brain membranes, and by [3H]U69,593 (KOR) using guinea-pig brain membranes, determined in competition binding assays. (B) Concentration-dependent stimulation of [35S]GTPγS binding by POMO and 14-OMO determined in the [35S]GTPγS binding assays using membranes from CHO cells expressing human opioid receptors. Percentage stimulation is presented relative to the maximum simulation of reference agonists DAMGO (MOR), DPDPE (DOR), and U69,593 (KOR). Values are expressed as the mean ± SEM (n ≥ 3).